Literature DB >> 17307664

Inverse correlation between tumor perfusion and glucose uptake in human head and neck tumors.

Satoshi Hirasawa1, Yoshito Tsushima, Hiroyuki Takei, Hiromi Hirasawa, Ayako Taketomi-Takahashi, Akie Takano, Noboru Oriuchi, Keigo Endo.   

Abstract

RATIONALE AND
OBJECTIVES: We sought to determine the relationship between tumor blood flow and glucose uptake in head and neck tumors using perfusion computed tomography (PCT) and fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET).
MATERIALS AND METHODS: Institutional review board approval and informed consent were obtained for this study. Sixteen patients (mean age, 67 years; age range, 36-89 years) who had known or suspected head and neck tumors (15 malignant tumors and one schwannoma) underwent PCT and FDG PET examinations. Tumor area was measured on conventional CT images. The PCT data were postprocessed using maximum slope method analysis, and standardized uptake value (SUV) was measured on FDG PET.
RESULTS: Mean arterial perfusion of the tumors was 61.56 mL/min/100 mL (range 22.17-102.7 mL/min/100 mL), and mean FDG SUV was 7.48 (range 2.74-17.1). A significant negative correlation between arterial perfusion and FDG SUV was found for malignant tumors (r = -0.538, P = .04, n = 15).
CONCLUSION: There was an inverse relationship between arterial perfusion and glucose uptake of head and neck malignant tumors, suggesting that the malignant tumors may depend on anaerobic glycolysis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17307664     DOI: 10.1016/j.acra.2006.12.017

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  15 in total

1.  Investigating tumor perfusion and metabolism using multiple hyperpolarized (13)C compounds: HP001, pyruvate and urea.

Authors:  Cornelius von Morze; Peder E Z Larson; Simon Hu; Hikari A I Yoshihara; Robert A Bok; Andrei Goga; Jan Henrik Ardenkjaer-Larsen; Daniel B Vigneron
Journal:  Magn Reson Imaging       Date:  2011-12-12       Impact factor: 2.546

2.  Combined PET/CT-perfusion in patients with head and neck cancers.

Authors:  Patrick Veit-Haibach; Daniel Schmid; Klaus Strobel; Jan D Soyka; Niklaus G Schaefer; Stephan K Haerle; Gerhard Huber; Gabriele Studer; Burkhardt Seifert; Thomas F Hany
Journal:  Eur Radiol       Date:  2012-07-08       Impact factor: 5.315

3.  Integrated ¹⁸F-FDG PET/perfusion CT for the monitoring of neoadjuvant chemoradiotherapy in rectal carcinoma: correlation with histopathology.

Authors:  Michael A Fischer; Bart Vrugt; Hatem Alkadhi; Dieter Hahnloser; Thomas F Hany; Patrick Veit-Haibach
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-24       Impact factor: 9.236

4.  An exploratory pilot study into the association between microcirculatory parameters derived by MRI-based pharmacokinetic analysis and glucose utilization estimated by PET-CT imaging in head and neck cancer.

Authors:  Sotirios Bisdas; Oliver Seitz; Markus Middendorp; Nicole Chambron-Pinho; Theodosios Bisdas; Thomas J Vogl; Renate Hammerstingl; Ulrike Ernemann; Martin G Mack
Journal:  Eur Radiol       Date:  2010-05-05       Impact factor: 5.315

5.  Cancer-associated stroma affects FDG uptake in experimental carcinomas. Implications for FDG-PET delineation of radiotherapy target.

Authors:  Paolo Farace; Daniela D'Ambrosio; Flavia Merigo; Mirco Galiè; Cristina Nanni; Antonello Spinelli; Stefano Fanti; Anna Degrassi; Andrea Sbarbati; Domenico Rubello; Pasquina Marzola
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-18       Impact factor: 9.236

6.  Whole-tumor perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positron-emission tomography/CT imaging.

Authors:  S Bisdas; K Spicer; Z Rumboldt
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-15       Impact factor: 3.825

7.  Correlation between [¹⁸F]FDG PET/CT and volume perfusion CT in primary tumours and mediastinal lymph nodes of non-small-cell lung cancer.

Authors:  Alexander W Sauter; Daniel Spira; Maximilian Schulze; Christina Pfannenberg; Jürgen Hetzel; Matthias Reimold; Ernst Klotz; Claus D Claussen; Marius S Horger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-10       Impact factor: 9.236

8.  Demonstrating Intertumoural Differences in Vascular-Metabolic Phenotype with Dynamic Contrast-Enhanced CT-PET.

Authors:  K A Miles; R E Williams; D Yu; M R Griffiths
Journal:  Int J Mol Imaging       Date:  2011-04-26

Review 9.  PET-CT in oncology: making the most of CT.

Authors:  K A Miles
Journal:  Cancer Imaging       Date:  2008-10-04       Impact factor: 3.909

Review 10.  Warburg revisited: imaging tumour blood flow and metabolism.

Authors:  K A Miles; R E Williams
Journal:  Cancer Imaging       Date:  2008-03-25       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.